Clinical Trial Detail

NCT ID NCT02159950
Title Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

prostate cancer

Therapies

Sipuleucel-T

Tasquinimod

Age Groups: adult

No variant requirements are available.